IKE Tech Celebrates FDA's Acknowledgment of Advanced Age Verification for Nicotine Products IKE Tech LLC is pleased with the FDA's new guidance recognizing the role of device-level age verification in regulating nicotine products, marking a pivotal moment in public health.

IKE Tech Celebrates FDA's Acknowledgment of Advanced Age Verification for Nicotine Products #United_States #Los_Angeles #Age_Verification #FDA_Guidance #IKE_Tech

Consegna Pharma's Innovative Strategy to Combat Opioid Epidemic Gains FDA Support for CP217 Consegna Pharma receives FDA approval for its innovative modeling strategy for CP217, an effective solution to prevent deaths from the opioid epidemic.

Consegna Pharma's Innovative Strategy to Combat Opioid Epidemic Gains FDA Support for CP217 #USA #Pittsburgh #FDA_Guidance #Consegna_Pharma #CP217

Diamyd Medical's Phase 3 Diabetes Trial Readout Accelerated by FDA Guidance Diamyd Medical has received FDA approval to accelerate the readout of its Phase 3 trial for type 1 diabetes, enhancing timelines for efficacy evaluation and patient treatment options.

Diamyd Medical's Phase 3 Diabetes Trial Readout Accelerated by FDA Guidance #USA #Stockholm #Type_1_Diabetes #Diamyd_Medical #FDA_Guidance

FDA Introduces Guidance to Enhance the Credibility of AI in Drug Product Submissions The FDA released new draft guidance aiming to establish trust in artificial intelligence models for drug and biological product submissions, fostering innovation.

FDA Introduces Guidance to Enhance the Credibility of AI in Drug Product Submissions #United_States #Silver_Spring #Drug_Development #FDA_Guidance #AI_Models